Phase 2 Interstitial Cystitis Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions
Bladder Pain SyndromeICHunner Type Interstitial Cystitis
JSC NextGen180 enrolled1 locationNCT07459790
Recruiting
Phase 2Phase 3
The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.
ICInterstitial Cystitis and Bladder Pain SyndromeInterstitial Cystitis, Chronic
JSC NextGen180 enrolled1 locationNCT07391306
Recruiting
Phase 2
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc.120 enrolled14 locationsNCT05737121
Recruiting
Phase 2
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc.50 enrolled5 locationsNCT06394830
Recruiting
Phase 2Phase 3
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
Interstitial CystitisPainful Bladder SyndromePainful Bladder Syndrome (PBS)
David Sheyn100 enrolled1 locationNCT06096597
Recruiting
Phase 1Phase 2
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
Interstitial Cystitis
University of Louisville100 enrolled1 locationNCT04845217
Completed
Phase 2
Botulinum Toxin A (BTXA) versus Hydrodistension for Refractory Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)- a Multicentre, Prospective, Randomized, Double Blind Study
interstitial cystitis/painful bladder syndrome
John Hunter Hospital50 enrolled1 locationACTRN12612000216819